Co-administration of sitagliptin and metformin had an additive effect on active GLP-1 concentrations
Vial sizing on the research-chemical market reflects commercial packaging convention, not a dose derived from the literature
Currently, there are ten classes of orally available pharmacological agents to treat T2DM: 1) sulfonylureas, 2) meglitinides, 3) metformin (a biguanide), 4) thiazolidinediones (TZDs), 5) alpha glucosidase inhibitors, 6) dipeptidyl peptidase IV (DPP-4) inhibitors, 7) bile acid sequestrants, 8) dopamine agonists, 9) sodium-glucose transport protein 2 (SGLT2) inhibitors and 10) oral glucagon like peptide 1 (GLP-1) receptor agonists
Angiogenesis, the formation of new blood vessels, plays a central role in tissue repair
In addition to greatly reducing HbA1c levels, tirzepatide treatment was not associated with increased cardiovascular risk [7, 26]
Rizvi has nothing to disclose